Pharmaceutica Analytica Acta

Pharmacy education in the UK and potential partnership opportunities with universities in Europe

17^th Annual Congress on Pharmaceutics & Drug Delivery Systems

September 20-22, 2018 Prague, Czech Republic

Raid G Alany

Kingston University, UK

Keynote: Pharm Anal Acta

Abstract:

Currently, there are 26 UK-based universities that offer the Master of Pharmacy (MPharm) degree, which is one of the main requirements to practice pharmacy in the UK. To register as a pharmacist in the UK, one must successfully complete a GPhC accredited (MPharm) course, which is a full-time, four-year course followed by successful completion of one year's pre-registration training, a period of paid employment in a community or hospital pharmacy during which a trainee is required to build up a portfolio of evidence and demonstrate their competence whilst being observed at work. This is followed by successful completion of the GPhC's registration exam along with meeting the fitness to practice requirements for registration as a pharmacist. On the other hand; courses in pharmaceutical sciences (BSc and MSc) throughout the UK are aimed at training graduates and preparing them to work in the pharmaceutical industry or specialize in regulatory affairs or clinical trials. Universities in the UK are reaching out to universities around the world to establish partnerships for joint provision. Such partnerships could come in various shapes and forms. The QAA UK quality code defines collaborative provision as learning opportunities leading or contributing to the award of academic credit or a qualification that is delivered, assessed or supported through an arrangement with one or more organizations other than the degree-awarding body???. Validation, franchise, dual degree, double degree, joint degree, articulation and placements are terms that are used in this context and could be rather confusing. This key note will cover the key aspects of pharmacy/pharmaceutical sciences education in the UK. This will be followed by an explanation of the various forms of joint academic provisions that are already in place and are available to pursue by universities in Europe should they wish to partner with a UK-based university.

Biography :

Raid G Alany is a registered New Zealand Pharmacist with a PhD from the University of Otago, Dunedin, New Zealand. He is the Inaugural Head of School of Life Sciences, Pharmacy and Chemistry at Kingston University London, UK; holds an Honorary Professorship at the University of Auckland, New Zealand. He is an Editor-in-Chief of the Pharmaceutical Development and Technology (Taylor and Francis), and is the Past President of the New Zealand Chapter of the Controlled Release Society. His research is on ophthalmic drug delivery, lipid and surfactant-based systems, in-situ gels and animal health. He holds international patents that have been commercialized in New Zealand and Australia, where he consults for animal health companies, regulatory bodies and IP-specialized law firms. His ResearchGate score is 39.23 and his H-index is 23 (Google scholar).

E-mail: r.alany@auckland.ac.nz